bullish
“Buy the Worst” Strategy into Year 3: What's on for 2022 to Beat the HSI?
648 Views30 Dec 2021 08:17
Our "Buy the Worst" strategy outperformed HSI by a massive 26.1pp YTD. For 2022, new names are Haidilao, Ali Health, Alibaba, Sands China and Xiaomi, based on YTD share price performance.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Rising
Osbert Tang, CFA
HK/China Equity Long-Short
- HK Tech Index Pressure Bleed into HSI Fresh Sell Zone21 Feb 2022
- Rising US Interest Rate: A Look at Which HK Blue Chips Are Less Vulnerable14 Feb 2022
- A Share Fizzle - HK Tech Bullish Base13 Jan 2022
- “Buy the Worst” Strategy into Year 3: What's on for 2022 to Beat the HSI?30 Dec 2021
- A Mid-Year Review of Our "Buy the Worst" Strategy: Outperformed HSI by 20.9pp12 Jul 2021
- A Review Of "Buy the Worst" Strategy in 2020 and Can It Beat the Hang Seng Index in 2021?30 Dec 2020
- "Buy the Worst" - A Simple Strategy to Beat the Hang Seng Index in 2020 and the Years to Come?23 Dec 2019
x